Skip to main content

Day: April 18, 2023

Form 8.3 – Dechra Pharmaceuticals Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Dechra Pharmaceuticals PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Correction: Dechra Pharmaceuticals Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Dechra Pharmaceuticals PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

Xalles Acquires Patient Healthcare Solutions

Xalles Expands Reach Into the U.S. Healthcare Financial Ecosystem WASHINGTON, D.C., April 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –  Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing technology and financial services solutions, today announced that it has executed and completed a Share Exchange Agreement with Patient Healthcare Solutions, Inc. (“PHCS”) to become a wholly owned subsidiary of Xalles Financial Services Inc. PHCS is a Florida-based Medical Services Organization (MSO). PHCS brings over 30 years of medical management experience and expertise, specifically in the venue of medical network management in the Tampa Bay metroplex market. A medical services organization is a business that provides non-medical and administrative services to physicians, hospitals and other healthcare practices, in order...

Continue reading

Ascent Solar Technologies, Inc. Accelerates Global Expansion Through Completed Acquisition of Swiss Thin-Film Solar Manufacturing Equipment

Ascent Solar’s acquisition of Flisom AG’s Zurich equipment establishes a new revenue stream, 300% more manufacturing capacity, and an international presence as European and Asian governments adopt legislation to increase solar energy production & domestic manufacturing capabilities THORNTON, Colo. and NIEDERHASLI, Switzerland, April 18, 2023 (GLOBE NEWSWIRE) — Ascent Solar Technologies, Inc. (NASDAQ: ASTI) (“ASTI” or the “Company”), the leading U.S. innovator in the design and manufacture of featherweight, flexible, and durable CIGS thin-film photovoltaic (PV) solutions, announced today that it has completed a transaction to acquire the Zurich-based manufacturing assets of thin-film solar manufacturer, Flisom AG. The Company will continue to be headquartered in Thornton, CO and will commence manufacturing using its new...

Continue reading

Viemed Accelerates Growth Through Acquisition of Tennessee Based Home Medical Products, Inc.

LAFAYETTE, La., April 18, 2023 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has entered into a definitive agreement to acquire Tennessee based Home Medical Products, Inc. (“HMP”), a large regional provider of respiratory focused home medical solutions. “We are incredibly excited to complement our strong history of organic growth by combining great teams through accretive transactions” said Viemed Chief Executive Officer Casey Hoyt. “The purchase of HMP will launch our acquisition growth initiatives with a stellar organization that has an extraordinary reputation with patients, payors, and physicians. Above all, the team at HMP shares our same driving passion for innovative...

Continue reading

Revolutionizing Energy Delivery: Transforming the Distribution Automation Market

SkyQuest’s Distribution Automation market report is an excellent analysis for individuals interested in gaining insight into the valuable data, trends, and opportunities in a rapidly growing industry. Additionally, the report is written clearly and concisely, making it accessible to various audiences, from industry experts to market readers. Finally, one can gain an in-depth understanding of the primary and secondary market drivers, providing them with a comprehensive outlook of the current market situation and future projections. Westford USA, April 18, 2023 (GLOBE NEWSWIRE) — SkyQuest projects that the Distribution Automation market will attain a value of USD 34.9 billion by 2030, with a CAGR of 7.4% over the forecast (2022-2030). New scientific advancements in IoT and communication devices are expected to drive demand...

Continue reading

Aben Minerals Amends Terms of Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Vancouver, BC, April 18, 2023 (GLOBE NEWSWIRE) — Aben Minerals Ltd. (TSX-V: ABM) (OTCQB: ABNAF) (Frankfurt: R26) (“Aben” or “the Company”) announces that it has amended the terms of the non-brokered private placement, as announced on April 4, 2023 (the “Placement”). The Company has reduced the price of the units issuable under the Placement (the “Units”) from $0.12 per Unit to $0.10 per Unit. The Company shall issue up to 5,000,000 Units of the Company for gross proceeds of up to CAD $500,000. Each Unit will now be comprised of one common share and one transferable warrant, entitling the holder to purchase one additional common share for a period of four (4) years at a price of CAD $0.15 per share. The Company intends to use the proceeds from...

Continue reading

Boralex will release its 2023 first quarter financial results on May 10

MONTREAL, April 18, 2023 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) announces that the release of the 2023 first quarter results will take place on Wednesday, May 10, 2023, at 9 a.m. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented. Date and time Wednesday, May 10, 2023, at 9 a.m. ET To attend the conference Webcast link: https://edge.media-server.com/mmc/p/3yfpeptp To attend the event by phone: Click here to register for the earnings call. Once you have completed your registration, you will receive a confirmation email containing the link and your personal PIN to connect to the call. If you lose this link and your PIN, you will be able to register again. You must register if you wish to attend the call by phone. Media and...

Continue reading

Boralex to hold virtual annual meeting of shareholders on May 10, 2023

MONTREAL, April 18, 2023 (GLOBE NEWSWIRE) — Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) announces that it will hold its Annual Meeting of Shareholders in a virtual-only format at 11:00 a.m. on Wednesday, May 10, 2023. The Annual Meeting will be broadcast online in audio only. Simultaneous interpretation will also be available for English-speaking participants. The online access to the event will start at 10:30 a.m. EDT. Shareholders will not be able to attend the meeting in person. Registered shareholders and duly appointed proxyholders will be able to attend the meeting, ask questions and vote, all in real time, if they are connected to the Internet and fulfill the conditions set out in the Management Information Circular. Non-registered shareholders (shareholders who hold their Boralex shares through a securities broker,...

Continue reading

FDCTech’s 2022 Annual Report Highlights: Record revenue and gross margin set the platform for future profitable growth

The Company’s successful integration of wealth management and enhanced technology businesses drive a 1,310% increase in annual revenue and a staggering 2,310% increase in gross margin. Irvine, CA, April 18, 2023 (GLOBE NEWSWIRE) — FDCTech, Inc. (“FDC” or the “Company,” OTCQB: FDCT), a fintech-driven company specializing in buying and integrating small to mid-size legacy financial services companies, today announced the following results for the fiscal year ending December 31, 2022, as compared to the corresponding period of last fiscal year:The revenues generated for the fiscal year ended December 31, 2022, and 2021 were $6,453,732 and $457,661, an increase of 1,310% from the previous period. The technology revenues generated for the fiscal year ended December 31, 2022, and 2021 were $626,000 and $301,648,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.